CRL-1322: Breast Cancer

Charles River Laboratories


Related Models
PDX model Engraftment
Host Strain Name Site Type Material Material Status Passage
Not Specified NMRI
Not Specified Not Specified Not Specified Not Specified 7
NMRI Crl:NMRI-Foxn1nu
subcutaneous heterotopic tissue fragment Not Specified 0, 4, 6
NMRI Crl:NMRI-Foxn1nu
Not Specified Not Specified Not Specified Not Specified 12, 7
Model Quality Control
Technique Description Passage
histology high concordance between xenograft passages <5,12,20
Patient
Sex female
Ethnicity caucasian
Derived Model CRL-1322
Patient Tumor Collection For PDX Model
Collection (Current Model)
Age 49
Diagnosis Breast Cancer
Type metastatic
PDX Mouse CRL-1322
Collection Site brain
Grade g3
Stage m1 ( Classification: tnm)
Date Regimen Started Regimen Dose Best Response Duration (Months)
Radiation Therapy NA Not Specified NA
Sample ID Sample Type Engrafted Tumor Passage Data Type Data Available Platform Used Raw Data
MAXF_1322-1230 Engrafted Tumor Passage 6 expression View data Affymetrix HGU133plus2 Not Available
MAXF_1322-1230 Engrafted Tumor Passage 6 mutation View data Illumina WES Not Available
MAXF_1322-1230 Engrafted Tumor Passage 6 copy number alteration View data Affymetrix SNP6.0 Not Available
Oncotest-101B Engrafted Tumor Passage 7 mutation View data Illumina WES Not Available
MAXF_1322-1230 Engrafted Tumor Passage 7 copy number alteration View data Affymetrix SNP6.0 Not Available
C01R0001 Engrafted Tumor Passage 12 mutation View data ILLUMINA Not Available
C01R0001 Engrafted Tumor Passage 12 mutation View data RNA sequencing Not Available
C01R0001 Engrafted Tumor Passage 12 expression View data ILLUMINA Not Available
1322 Engrafted Tumor Passage 4 cytogenetics View data Immunohistochemistry Not Available

Sample ID:     Histology:     Tumor Type: Engrafted Tumor     Passage:     Platform: